Display options
Share it on

JMIR Res Protoc. 2018 Feb 26;7(2):e51. doi: 10.2196/resprot.9118.

Enhancing Survivorship Care Planning for Patients With Localized Prostate Cancer Using a Couple-Focused mHealth Symptom Self-Management Program: Protocol for a Feasibility Study.

JMIR research protocols

Lixin Song, Kaitlyn L Dunlap, Xianming Tan, Ronald C Chen, Matthew E Nielsen, Rebecca L Rabenberg, Josephine K Asafu-Adjei, Bridget F Koontz, Sarah A Birken, Laurel L Northouse, Deborah K Mayer

Affiliations

  1. School of Nursing, University of North Carolina, Chapel Hill, NC, United States.
  2. Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina, Chapel Hill, NC, United States.
  3. University of North Carolina, Chapel Hill, NC, United States.
  4. School of Medicine, Duke University, Durham, NC, United States.
  5. School of Nursing, University of Michigan, Ann Arbor, MI, United States.

PMID: 29483070 PMCID: PMC5847815 DOI: 10.2196/resprot.9118

Abstract

BACKGROUND: This project explores a new model of care that enhances survivorship care planning and promotes health for men with localized prostate cancer transitioning to posttreatment self-management. Survivorship care planning is important for patients with prostate cancer because of its high incidence rate in the United States, the frequent occurrence of treatment-related side effects, and reduced quality of life (QOL) for both men and their partners. A key component of comprehensive survivorship care planning is survivorship care plans (SCPs), documents that summarize cancer diagnosis, treatment, and plans for follow-up care. However, research concerning the effectiveness of SCPs on patient outcomes or health service use has thus far been inconclusive. SCPs that are tailored to individual patients' needs for information and care may improve effectiveness.

OBJECTIVE: This study aims to examine the feasibility of an enhanced survivorship care plan (ESCP) that integrates a symptom self-management mHealth program called Prostate Cancer Education and Resources for Couples (PERC) into the existing standardized SCP. The specific aims are to (1) examine the feasibility of delivering ESCPs and (2) to estimate the magnitude of benefit of ESCPs.

METHODS: We will use a two-group randomized controlled pretest-posttest design and collect data at baseline (T1) and 4 months later (T2) among 50 patients completing initial treatment for localized prostate cancer and their partners. First, we will assess the feasibility of ESCP by recruitment, enrollment, and retention rates; program satisfaction with the ESCP; and perceived ease of use of the ESCP. To achieve the secondary aim, we will compare the ESCP users with the standardized SCP users and assess their primary outcomes of QOL (overall, physical, emotional, and social QOL); secondary outcomes (reduction in negative appraisals and improvement in self-efficacy, social support, and health behaviors to manage symptoms); and number of visits to posttreatment care services between T1 and T2. We will assess the primary and secondary outcomes using measurements with sound psychometrical properties. We will use a qualitative and quantitative mixed methods approach to achieve the research aims.

RESULTS: This project is ongoing and will be completed by the end of 2018.

CONCLUSIONS: The results from this study will help design a definitive randomized trial to test the efficacy of the ESCPs, a potentially scalable program, to enhance supportive care for prostate cancer patients and their families.

©Lixin Song, Kaitlyn L Dunlap, Xianming Tan, Ronald C Chen, Matthew E Nielsen, Rebecca L Rabenberg, Josephine K Asafu-Adjei, Bridget F Koontz, Sarah A Birken, Laurel L Northouse, Deborah K Mayer. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 26.02.2018.

Keywords: Patient Reported Outcome Measures; caregiver; mHealth; prostate cancer; survivorship; symptom, randomized trial

References

  1. Br J Cancer. 2013 May 14;108(9):1784-9 - PubMed
  2. Qual Life Res. 2011 Apr;20(3):371-81 - PubMed
  3. BJU Int. 2012 Dec;110(11):1690-5 - PubMed
  4. Psychooncology. 2012 Jan;21(1):72-81 - PubMed
  5. Qual Life Res. 2014 Oct;23(8):2309-17 - PubMed
  6. J Clin Oncol. 2011 Feb 1;29(4):362-8 - PubMed
  7. Int J Aging Hum Dev. 2000;51(1):5-29 - PubMed
  8. J Adv Nurs. 2013 Nov;69(11):2572-83 - PubMed
  9. Cancer Nurs. 2013 May-Jun;36(3):E7-E14 - PubMed
  10. Int J Med Inform. 2010 Apr;79(4):e18-23 - PubMed
  11. J Oncol Pract. 2012 Jul;8(4):e80-6 - PubMed
  12. J Cancer Surviv. 2011 Dec;5(4):337-44 - PubMed
  13. Am J Epidemiol. 2011 Mar 15;173(6):676-82 - PubMed
  14. Urology. 2000 Dec 20;56(6):899-905 - PubMed
  15. Psychooncology. 2010 Sep;19(9):909-22 - PubMed
  16. Oncol Nurs Forum. 2015 Mar;42(2):183-92 - PubMed
  17. J Chronic Dis. 1987;40(5):373-83 - PubMed
  18. J Clin Oncol. 2002 Oct 1;20(19):4050-64 - PubMed
  19. BMC Fam Pract. 2014 May 13;15:94 - PubMed
  20. J Clin Nurs. 2015 May;24(9-10):1367-79 - PubMed
  21. Rev Urol. 2013;15(4):161-77 - PubMed
  22. Am J Public Health. 2009 Dec;99(12):2123-7 - PubMed
  23. ANS Adv Nurs Sci. 1988 Oct;11(1):76-90 - PubMed
  24. Psychooncology. 2011 Feb;20(2):155-64 - PubMed
  25. J Clin Oncol. 1993 Mar;11(3):570-9 - PubMed
  26. Chronic Illn. 2013 Jun;9(2):145-55 - PubMed
  27. J Cancer Surviv. 2014 Dec;8(4):595-602 - PubMed
  28. Cancer. 2015 Apr 1;121(7):978-96 - PubMed
  29. BMC Cancer. 2013 Feb 26;13:89 - PubMed
  30. J Natl Cancer Inst. 2009 Jun 16;101(12):888-92 - PubMed
  31. J Cancer Surviv. 2015 Dec;9(4):683-91 - PubMed
  32. J Cancer Surviv. 2011 Jun;5(2):132-41 - PubMed
  33. Cancer. 2012 Nov 15;118(22):5679-87 - PubMed
  34. Eur Urol. 2014 May;65(5):856-64 - PubMed
  35. BMC Cancer. 2012 Jul 24;12:312 - PubMed
  36. N Engl J Med. 2008 Mar 20;358(12):1250-61 - PubMed
  37. J Cancer Educ. 2015 Jun;30(2):312-8 - PubMed
  38. J Clin Oncol. 2007 Sep 20;25(27):4171-7 - PubMed
  39. CA Cancer J Clin. 2014 Jul-Aug;64(4):225-49 - PubMed
  40. J Gerontol Nurs. 2012 Jul;38(7):38-43 - PubMed
  41. Psychooncology. 2013 Feb;22(2):475-9 - PubMed
  42. J Clin Oncol. 2015 Nov 1;33(31):3550-9 - PubMed
  43. Holist Nurs Pract. 2013 May-Jun;27(3):140-7 - PubMed
  44. Patient Educ Couns. 2010 Dec;81 Suppl:S100-10 - PubMed
  45. Cancer. 2007 Dec 15;110(12):2809-18 - PubMed
  46. J Clin Oncol. 2011 Dec 20;29(36):4755-62 - PubMed
  47. Semin Oncol Nurs. 2011 Nov;27(4):300-8 - PubMed
  48. Patient Educ Couns. 2009 Nov;77(2):179-86 - PubMed
  49. J Natl Cancer Inst. 2014 Sep 22;106(11):null - PubMed
  50. BMC Cancer. 2008 Aug 08;8:226 - PubMed

Publication Types

Grant support